Staphylococcus aureus Bacteremia: Contemporary Management

bacteremia (SAB) is a serious cause of bloodstream infection associated with significant morbidity and mortality. Complications include deep-seated foci of infection including infective endocarditis, device-associated infection, osteoarticular metastases, pleuropulmonary involvement, and recurrent i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Missouri medicine 2020-07, Vol.117 (4), p.341-345
Hauptverfasser:	Abraham, Leny, Bamberger, David M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Antimicrobial Stewardship - methods Antimicrobial Stewardship - standards Antimicrobial Stewardship - statistics & numerical data Bacteremia - drug therapy Bacteremia - etiology Bacteremia - physiopathology Catheters Cohort analysis Disease control Drug dosages Endocarditis Health care policy Hemodialysis Hospitals Humans Infectious diseases Longitudinal studies Metastasis Mortality Pneumonia Prostheses Risk Factors Staphylococcal Infections - drug therapy Staphylococcal Infections - etiology Staphylococcal Infections - physiopathology Staphylococcus aureus - drug effects Staphylococcus aureus - pathogenicity Staphylococcus infections Treatment Outcome Ultrasonic imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	bacteremia (SAB) is a serious cause of bloodstream infection associated with significant morbidity and mortality. Complications include deep-seated foci of infection including infective endocarditis, device-associated infection, osteoarticular metastases, pleuropulmonary involvement, and recurrent infection. With the 30-day all-cause mortality being around 20%, a collaborative effort of early Infectious Diseases (ID) consultation and Antimicrobial Stewardship Program (ASP) involvement will show improved SAB outcomes and therapy optimization.1.
ISSN:	0026-6620